NRIX

NRIX

USD

Nurix Therapeutics Inc. Common stock

$12.260-0.040 (-0.325%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$12.300

High

$12.530

Low

$12.160

Volume

1.16M

Company Fundamentals

Market Cap

1.2B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.24M

Exchange

NGM

Currency

USD

52-Week Range

Low $8.18Current $12.260High $29.56

Related News

Analyst Upgrades

Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target

Needham analyst Gil Blum reiterates Nurix Therapeutics with a Buy and maintains $26 price target.

View more
Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target
Analyst Upgrades

BTIG Reiterates Buy on Nurix Therapeutics, Maintains $27 Price Target

BTIG analyst Jeet Mukherjee reiterates Nurix Therapeutics with a Buy and maintains $27 price target.

View more
BTIG Reiterates Buy on Nurix Therapeutics, Maintains $27 Price Target
GlobeNewswire

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein

View more
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire

Nurix Therapeutics to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein

View more
Nurix Therapeutics to Participate in Upcoming Investor Conferences